Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Dynamic ploidy changes drive fluconazole resistance in human cryptococcal meningitis
Neil Stone, Johanna Rhodes, Matthew C. Fisher, et al.
Journal of Clinical Investigation (2019) Vol. 129, Iss. 3, pp. 999-1014
Open Access | Times Cited: 142

Showing 1-25 of 142 citing articles:

Tackling the emerging threat of antifungal resistance to human health
Matthew C. Fisher, Ana Alastruey‐Izquierdo, Judith Berman, et al.
Nature Reviews Microbiology (2022) Vol. 20, Iss. 9, pp. 557-571
Open Access | Times Cited: 698
Drug resistance and tolerance in fungi
Judith Berman, Damian J. Krysan
Nature Reviews Microbiology (2020) Vol. 18, Iss. 6, pp. 319-331
Open Access | Times Cited: 487
Treatment strategies for cryptococcal infection: challenges, advances and future outlook
Kali R. Iyer, Nicole M. Revie, Ci Fu, et al.
Nature Reviews Microbiology (2021) Vol. 19, Iss. 7, pp. 454-466
Open Access | Times Cited: 258
The impact of the Fungus-Host-Microbiota interplay uponCandida albicansinfections: current knowledge and new perspectives
Christophe d’Enfert, Ann-Kristin Kaune, Leovigildo-Rey Alaban, et al.
FEMS Microbiology Reviews (2020) Vol. 45, Iss. 3
Open Access | Times Cited: 236
Drug-Resistant Fungi: An Emerging Challenge Threatening Our Limited Antifungal Armamentarium
Amir Arastehfar, Toni Gabaldón, Rocio Garcia‐Rubio, et al.
Antibiotics (2020) Vol. 9, Iss. 12, pp. 877-877
Open Access | Times Cited: 212
The Fungal CYP51s: Their Functions, Structures, Related Drug Resistance, and Inhibitors
Jingxiang Zhang, Liping Li, Quanzhen Lv, et al.
Frontiers in Microbiology (2019) Vol. 10
Open Access | Times Cited: 186
The importance of antimicrobial resistance in medical mycology
Neil A. R. Gow, Carolyn Johnson, Judith Berman, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 152
Effects of aneuploidy on cell behaviour and function
Rong Li, Jin Zhu
Nature Reviews Molecular Cell Biology (2022) Vol. 23, Iss. 4, pp. 250-265
Closed Access | Times Cited: 103
Cryptococcus neoformans, a global threat to human health
Youbao Zhao, Leixin Ye, Fujie Zhao, et al.
Infectious Diseases of Poverty (2023) Vol. 12, Iss. 1
Open Access | Times Cited: 102
Global guideline for the diagnosis and management of cryptococcosis: an initiative of the ECMM and ISHAM in cooperation with the ASM
Christina C. Chang, Thomas S. Harrison, Tihana Bicanic, et al.
The Lancet Infectious Diseases (2024) Vol. 24, Iss. 8, pp. e495-e512
Open Access | Times Cited: 80
Novel antifungals and treatment approaches to tackle resistance and improve outcomes of invasive fungal disease
Martin Hoenigl, Amir Arastehfar, Maiken Cavling Arendrup, et al.
Clinical Microbiology Reviews (2024) Vol. 37, Iss. 2
Closed Access | Times Cited: 33
Combatting the evolution of antifungal resistance in Cryptococcus neoformans
Arianne Bermas, Jennifer Geddes‐McAlister
Molecular Microbiology (2020) Vol. 114, Iss. 5, pp. 721-734
Open Access | Times Cited: 108
Epigenetic gene silencing by heterochromatin primes fungal resistance
Sito Torres-Garcia, Imtiyaz Yaseen, Manu Shukla, et al.
Nature (2020) Vol. 585, Iss. 7825, pp. 453-458
Open Access | Times Cited: 98
Gene Duplication Associated with Increased Fluconazole Tolerance in Candida auris cells of Advanced Generational Age
Somanon Bhattacharya, Thomas Holowka, Erika P. Orner, et al.
Scientific Reports (2019) Vol. 9, Iss. 1
Open Access | Times Cited: 86
Resistance to Antifungal Drugs
Ronen Ben‐Ami, Dimitrios P. Kontoyiannis
Infectious Disease Clinics of North America (2021) Vol. 35, Iss. 2, pp. 279-311
Closed Access | Times Cited: 71
Antifungal drug resistance: an update
David W. Denning
European Journal of Hospital Pharmacy (2022) Vol. 29, Iss. 2, pp. 109-112
Open Access | Times Cited: 66
Drug Resistance and Novel Therapeutic Approaches in Invasive Candidiasis
Sarah E. Murphy, Tihana Bicanic
Frontiers in Cellular and Infection Microbiology (2021) Vol. 11
Open Access | Times Cited: 61
Molecular Mechanisms of 5-Fluorocytosine Resistance in Yeasts and Filamentous Fungi
Fatima Zohra Delma, Abdullah M. S. Al‐Hatmi, Roger J. M. Brüggemann, et al.
Journal of Fungi (2021) Vol. 7, Iss. 11, pp. 909-909
Open Access | Times Cited: 58
Molecular mechanisms of acquired antifungal drug resistance in principal fungal pathogens and EUCAST guidance for their laboratory detection and clinical implications
Thomas R. Rogers, Paul E. Verweij, Mariana Castanheira, et al.
Journal of Antimicrobial Chemotherapy (2022) Vol. 77, Iss. 8, pp. 2053-2073
Open Access | Times Cited: 55
Prevention of antimicrobial resistance in sub-Saharan Africa: What has worked? What still needs to be done?
Perseverance Moyo, Enos Moyo, Derek Mangoya, et al.
Journal of Infection and Public Health (2023) Vol. 16, Iss. 4, pp. 632-639
Open Access | Times Cited: 40
A One Health approach to overcoming fungal disease and antifungal resistance
Michael Woods, Jason A. McAlister, Jennifer Geddes‐McAlister
WIREs Mechanisms of Disease (2023) Vol. 15, Iss. 4
Open Access | Times Cited: 34
Antifungal heteroresistance causes prophylaxis failure and facilitates breakthrough Candida parapsilosis infections
Bing Zhai, Chen Liao, Siddharth Jaggavarapu, et al.
Nature Medicine (2024) Vol. 30, Iss. 11, pp. 3163-3172
Closed Access | Times Cited: 15
Beyond resistance: antifungal heteroresistance and antifungal tolerance in fungal pathogens
Feng Yang, Judith Berman
Current Opinion in Microbiology (2024) Vol. 78, pp. 102439-102439
Closed Access | Times Cited: 14
Fluconazole Monotherapy Is a Suboptimal Option for Initial Treatment of Cryptococcal Meningitis Because of Emergence of Resistance
William Hope, Neil Stone, Adam Johnson, et al.
mBio (2019) Vol. 10, Iss. 6
Open Access | Times Cited: 63
A titanic drug resistance threat in Cryptococcus neoformans
Hanna Zafar, Sophie Altamirano, Elizabeth R. Ballou, et al.
Current Opinion in Microbiology (2019) Vol. 52, pp. 158-164
Open Access | Times Cited: 62
Page 1 - Next Page

Scroll to top